Sight Sciences, Inc. (SGHT)
NASDAQ: SGHT · Real-Time Price · USD
9.24
+0.21 (2.33%)
At close: Oct 28, 2026, 4:00 PM EDT
9.14
-0.10 (-1.04%)
After-hours: Oct 28, 2026, 7:30 PM EDT
Sight Sciences Employees
Sight Sciences had 186 employees as of December 31, 2025. The number of employees decreased by 30 or 13.89% compared to the previous year. That makes Sight Sciences the 27,340th largest employer in the world and 3,463rd in the United States.
Employees
186
Change (1Y)
-30
Growth (1Y)
-13.89%
Revenue / Employee
$448,263
Profits / Employee
-$159,984
Market Cap
509.01M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 186 | -30 | -13.89% |
| Dec 31, 2024 | 216 | 2 | 0.93% |
| Dec 31, 2023 | 214 | -36 | -14.40% |
| Dec 31, 2022 | 250 | 38 | 17.92% |
| Dec 31, 2021 | 212 | 43 | 25.44% |
| Mar 31, 2021 | 169 | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Tactile Systems Technology | 1,086 |
| SS Innovations International | 483 |
| Cerus | 275 |
| AVITA Medical | 226 |
| NeuroPace | 220 |
| Anteris Technologies Global | 174 |
| 908 Devices | 172 |
| Delcath Systems | 156 |
SGHT News
- 7 days ago - Sight Sciences to Report Third Quarter 2026 Financial Results on November 4, 2026 - GlobeNewsWire
- 13 days ago - Sight Sciences initiated with a Buy at H.C. Wainwright - TheFly
- 23 days ago - Citi ups Sight Sciences target, opens ‘upside 90-day catalyst watch’ - TheFly
- 27 days ago - Sight Sciences to Debut the OMNI Ultra® Surgical System, the Latest Technology Advancement from the Pioneers of Ab Interno Canaloplasty, at the 2026 American Academy of Ophthalmology (AAO) Annual Meeting - GlobeNewsWire
- 6 weeks ago - Sight Sciences Transcript: Morgan Stanley 24th Annual Global Healthcare Conference - Transcripts
- 1 month ago - Sight Sciences to Present at the Upcoming Morgan Stanley Global Healthcare Conference on September 15 - GlobeNewsWire
- 2 months ago - Sight Sciences announces updated TearCare System Indications for Use - TheFly
- 2 months ago - TearCare Becomes the First and Only MGD Treatment Indicated to Improve Meibomian Gland Function in Patients with Evaporative Dry Eye Disease - GlobeNewsWire